Learn More
Medchemexpress LLC Yl-5092 | 3056857-07-6 | 99.8% | 441.43 | C22H14F3N3O2S | 10 MG

Supplier: Medchemexpress LLC HY16460710MG
YL-5092 is a selective inhibitor of YT521-B homology (YTH) domain-containing protein 1 (YTHDC1) with potent biochemical activity and demonstrated efficacy in acute myeloid leukemia models. It is used in research probing m6A-mediated RNA regulation and cancer biology, and is supplied as a characterized, high-purity solid for in vitro and in vivo studies.
- Selective inhibition of YTHDC1 (IC50 7.4 nM; KD 29.6 nM).
- Demonstrated cellular activity against AML cell lines and efficacy in xenograft models.
- Induces G0/G1 phase arrest and apoptosis in cancer cells.
- High reported purity and defined physicochemical properties for reproducible results.
- Soluble in DMSO (100 mg/mL) and formulatable for in vivo use (≥2.5 mg/mL in standard vehicle).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.